Publications by authors named "Stuart L Klein"
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer.
Materials And Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended to undergo definitive PT; 547 patients (34.4%) had commercial insurance, whereas 1045 patients (65.
Purpose: To determine factors that influence insurance approval for breast cancer patients for whom adjuvant proton therapy (PT) is recommended.
Patients And Methods: We sought to identify factors associated with PT approval among 131 insured patients seen in consultation between 2014 and 2018 and recommended adjuvant PT. Insurance status included: commercial, 76 patients (58%); Medicare, 41 (31%); and Medicaid, 14 (11%).